Patents by Inventor Claudia Abeijon

Claudia Abeijon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170252365
    Abstract: This invention is directed to ?-1-6-glucans, compositions and devices comprising the same, and methods of use thereof in modulating immune responses. The ?-1-6-glucans of certain embodiments of the invention are enriched for O-acetylated groups and/or conjugated to a solid support or linked to a targeting moiety.
    Type: Application
    Filed: July 26, 2016
    Publication date: September 7, 2017
    Inventors: Ifat RUBIN-BEJERANO, Gerald R. FINK, Claudia ABEIJON, Daniel S. KOHANE, Jason E. FULLER, Robert S. LANGER
  • Publication number: 20160331774
    Abstract: This invention is directed to ?-1-6-glucans, compositions and devices comprising the same, and methods of use thereof in modulating immune responses. The ?-1-6-glucans of certain embodiments of the invention are enriched for O-acetylated groups and/or conjugated to a solid support or linked to a targeting moiety.
    Type: Application
    Filed: July 26, 2016
    Publication date: November 17, 2016
    Inventors: Ifat Rubin-Bejerano, Gerald R. Fink, Claudia Abeijon, Daniel S. Kohane, Jason E. Fuller, Robert S. Langer
  • Patent number: 9457047
    Abstract: This invention is directed to ?-1-6-glucans, compositions and devices comprising the same, and methods of use thereof in modulating immune responses. The ?-1-6-glucans of certain embodiments of the invention are enriched for O-acetylated groups and/or conjugated to a solid support or linked to a targeting moiety.
    Type: Grant
    Filed: September 26, 2013
    Date of Patent: October 4, 2016
    Assignees: Whitehead Institute, Massachusetts Institute of Technology, Trustees of Boston University, The General Hospital Corporation
    Inventors: Ifat Rubin-Bejerano, Gerald R. Fink, Claudia Abeijon, Daniel S. Kohane, Jason E Fuller, Robert S. Langer
  • Publication number: 20140030277
    Abstract: This invention is directed to ?-1-6-glucans, compositions and devices comprising the same, and methods of use thereof in modulating immune responses. The ?-1-6-glucans of certain embodiments of the invention are enriched for O-acetylated groups and/or conjugated to a solid support or linked to a targeting moiety.
    Type: Application
    Filed: September 26, 2013
    Publication date: January 30, 2014
    Applicants: Whitehead Institute, The General Hospital Corporation d/b/a Massachusetts General Hospital, Boston University, Massachusetts Institute of Technology
    Inventors: Ifat Rubin-Bejerano, Gerald R. Fink, Claudia Abeijon, Daniel S. Kohane, Jason E. Fuller, Robert S. Langer
  • Patent number: 8580253
    Abstract: This invention is directed to ?-1-6-glucans, compositions and devices comprising the same, and methods of use thereof in modulating immune responses. The ?-1-6-glucans of certain embodiments of the invention are enriched for O-acetylated groups and/or conjugated to a solid support or linked to a targeting moiety.
    Type: Grant
    Filed: November 6, 2007
    Date of Patent: November 12, 2013
    Assignees: Whitehead Institute, Massachusetts Institute of Technology, Trustees of Boston University, The General Hospital Corporation
    Inventors: Ifat Rubin-Bejerano, Gerald R. Fink, Claudia Abeijon, Danial S. Kohane, Jason E. Fuller, Robert S. Langer
  • Publication number: 20130236484
    Abstract: The present invention relates to isolated Visceral leishmaniasis (VL) antigens that are useful in therapeutic and vaccine compositions for stimulating a VL specific immunological response. The identified antigens are also useful in diagnostic assays to determine the presence of active VL in an individual. Combinations of antibodies raised against these antigens are especially useful in detection of VL infections. Accordingly, the present invention includes polypeptide molecules, nucleic acid molecules, vaccine compositions, diagnostic assays, and methods of diagnosis and monitoring treatment related to these VL antigens.
    Type: Application
    Filed: March 8, 2013
    Publication date: September 12, 2013
    Applicant: DETECTOGEN INC.
    Inventors: Antonio Campos-Neto, Claudia Abeijon
  • Publication number: 20110045049
    Abstract: This invention is directed to ?-1-6-glucans, compositions and devices comprising the same, and methods of use thereof in modulating immune responses. The ?-1-6-glucans of certain embodiments of the invention are enriched for O-acetylated groups and/or conjugated to a solid support or linked to a targeting moiety.
    Type: Application
    Filed: November 6, 2007
    Publication date: February 24, 2011
    Inventors: Ifat Rubin-Bejerano, Gerald R. Fink, Claudia Abeijon, Danial S. Kohane, Jason E. Fuller, Robert S. Langer